Kelly Lacob

Kelly Lacob is a healthcare technologist, product designer, and systems thinker redefining how

we deliver care—making it more preventive, personalized, and accessible. Trained at Stanford

and Johns Hopkins in human biology, bioengineering, and business, Kelly has built her career

translating early-stage science into scalable products that change lives for traditionally

underserved patient populations.

Before co-founding Xella Health, Kelly led the product design and roadmap for the first

CRISPR-powered diagnostic platform at Mammoth Biosciences, and the development and

launch of the first FDA-cleared point-of-care and at-home PCR test at Visby Medical—a

diagnostic breakthrough that helped power early COVID-19 response efforts. Her portfolio of

past products spans more than a dozen healthcare innovations, including a remote-monitoring

platform for hypertension, diabetes, and preeclampsia, a surgical-supply bundling solution that

reduced postoperative infection, a community-based hearing-screening platform enabling

task-shifting to lower-level health workers, and a smart wound sensor and mobile app to prevent

pressure sores.

Now as Co-Founder and CEO of Xella Health, Kelly is applying her expertise in product design

and commercialization to bridge the gap between cutting-edge research and everyday clinical

care for women and their families.